Test Your Knowledge Issue 265
Thirty years ago Dr. Gerald Reaven put 32 Type 2 diabetes patients, one at a time on the Biostator (artificial pancreas) for 2 weeks.
A New Face in The Crowd: FGF-21
Although we have a lot of information from ADA Evan David Rosen, M.D., Ph.D. Assistant Professor of Medicine, Harvard Medical School, brings us more research he uncovered about a new protein like drug from Lilly. FGF-21 is unique because as an...
The Importance of a Daily Multivitamin and Mineral Supplement For People with Di
The Importance of a Daily Multivitamin and Mineral Supplement
For People with Diabetes and Prediabetes There were some interesting abstracts on the use of nutrients in diabetes and Melissa Diane Smith, Dpl Nutrition shares information...
Symlin and Byetta
This week we have a cheat sheet on Symlin and Byetta. Information in a condensed format that you need to know when talking to patients who will be using the new drugs.
Beta-Cells Regenerate Even In Type 1 Diabetes
A new study provides evidence that the pancreas continues to form beta cells even in the setting of long-standing type 1diabetes.
DCCT Continues To Provide New Data:
CVD Events Lowered by 60% Years Later for Intensive Group.
By following the participants in the DCCT study since it’s conclusion in 1993, it has continued to provide new information. For the first time, intensive treatment of diabetic patients r...
Positive Results with Novo Nordisk A/S Long-Acting GLP-1 Analog and Gastrin Comb
Combination brings back normal blood glucose levels by increasing beta-cell mass.
FDA Approves Levemir(R) (insulin detemir [rDNA Origin] Injection)
A New, Long-Acting Insulin Treatment for Diabetes.
Denmark's Novo Nordisk said on Friday the United States Food and Drug Administration (FDA) has approved its long-acting 24 hr. insulin for treatment of diabetes.
Rimonabant Reduces Lipids, Weight, and Adiposity
Rimonabant, the first in the new drug class of CB1 blockers, was found to improve hemoglobin A1c (HbA1c) levels, reduce lipid levels and blood pressure, and reduce weight and waist size, researchers reported.
Cardiovascular Disease Already a Factor for Teens With Type 1 Diabetes
Artery walls begin thickening as early as the midteen years in young people with type 1 diabetes.
Exenatide Delivers Weight-Reduction Benefit in Type 2 Diabetes
Patients with type 2 diabetes who take the new incretin mimetic drug exenatide (Byetta) appear to achieve sustained glucose control and progressive weight reduction after 18 months of therapy.
Pre-Pregnancy Exercise Lowers Risk of Gestational Diabetes
Engaging in regular vigorous physical activity before pregnancy reduces the risk of gestational diabetes mellitus (GDM).
Incidence of Diagnosed Diabetes Jumped 41% in US
In 2003 alone, nearly 60% of new cases were obese, and an additional 30% were overweight.
Encapsulated Islet Cell Transplants Avoid Rejection
Encapsulating islets cells with polyethylene glycol -- may soon obviate the need for immunosuppression in islet cell transplantation.
Retinopathy Occurs Sooner In Prediabetes
Retinopathy can lead to blindness in people with diabetes and may occur far sooner than previously thought, possibly when patients are still in the prediabetes stage or when glucose levels are only slightly higher than normal.
Tesaglitazar Shows Promise
In Controlling Lipid and Glucose Levels.
The novel compound tesaglitazar (Galida) appears to be effective in reducing fasting glucose while decreasing triglyceride levels and increasing high-density lipoprotein (HDL) cholesterol levels.
Muraglitazar May Help Lower Glucose and Cholesterol Levels in Type 2 Diabetes
Two-in-one pill shows a reduction in plasma lipid levels and glucose levels.
Metaglidasen Controls Diabetes and Lipds Without Side Effects
The diabetes drug metaglidasen was shown to control blood glucose levels without causing weight gain or edema, according to a mid-stage clinical trial.
Aggressive Diabetes Education Program Makes Positive Impact
On Health of Medicaid Patients.
The program is projected to reduce diabetes-related mortality by 9 percent and microvascular disease events by 15 percent among those who completed the program.
Diabetes Hospitalization Rates Falling in US, CDC Says
The CDC study found that the rate of people with diabetes admitted to a hospital for a potentially preventable reason fell 35 percent between 1994 and 2002. And the rate of kidney failure in diabetes patients has fallen about 30 percent since 1996.
The Inhaled Insulin Exubera, Shows Effectiveness in Study
Exubera, an inhaled insulin powder, worked as well in a study of 226 patients as injectable insulin.
Chromium Significantly Reduced Weight Gain Associated with Anti-diabetic Medicat
Chromium picolinate reduced weight gain associated with anti-diabetes drugs and also improved blood sugar control and insulin sensitivity.
Nationwide Recall of Insulin Syringe 1-cc, 28-Gauge 1/2-Inch 100's
FDA Recalls the AccuSure Insulin Syringes made by Qualitest Pharmaceuticals, Inc.
